A History of Percutaneous Left Atrial Appendage Occlusion with the PLAATO Device

Heyder Omran; Apostolos Tzikas; Horst Sievert; Frederike Stock

doi:10.1016/j.iccl.2017.12.009

A History of Percutaneous Left Atrial Appendage Occlusion with the PLAATO Device

Interv Cardiol Clin. 2018 Apr;7(2):137-142. doi: 10.1016/j.iccl.2017.12.009.

Authors

Heyder Omran¹, Apostolos Tzikas², Horst Sievert³, Frederike Stock⁴

Affiliations

¹ Department of Cardiology, GFO Kliniken Bonn, Robert-Koch-Str. 1, Bonn 53115, Germany. Electronic address: [email protected].
² Department of Cardiology, AHEPA University Hospital, Kiriakidi 1 Street, Thessaloniki 54637, Greece.
³ Cardiovascular Center Frankfurt CVC, Seckbacher Landstraße 65, Frankfurt 60389, Germany.
⁴ Department of Cardiology, GFO Kliniken Bonn, Robert-Koch-Str. 1, Bonn 53115, Germany.

PMID: 29526282
DOI: 10.1016/j.iccl.2017.12.009

Abstract

Percutaneous left atrial appendage occlusion was introduced as an alternative method for prevention of thromboembolism in patients with nonvalvular atrial fibrillation after extensive animal work in 2001. The first device was named Percutaneous Left Atrial Appendage Transcatheter Occlusion (PLAATO) and patented by the company Appriva. The device was invented by Michael Lesh, MD.

Keywords: Atrial fibrillation; Left atrial appendage; Left atrial appendage occlusion; PLAATO.

Publication types

Review

MeSH terms

Animals
Atrial Appendage / diagnostic imaging
Atrial Appendage / surgery*
Atrial Fibrillation / complications*
Balloon Occlusion / instrumentation
Disease Models, Animal
Echocardiography / methods
Echocardiography, Transesophageal / methods
Equipment Design / instrumentation*
Humans
Therapeutic Occlusion / methods
Thromboembolism / prevention & control